|
High Court Could Take Up Generic Preemption Again: Mutual Petitions
Generic preemption issues may again wind up before the Supreme Court as generic maker Mutual Pharmaceutical is calling on it to reverse an appeals court decision that upheld a $21 million jury award to a patient injured by Mutual’s sulindac.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives